angiotensin ii has been researched along with Neoplasm Metastasis, Unknown Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ida, K; Kamiya, T | 1 |
| Anderson, JR; Goldberg, JA; Kerr, DJ; McArdle, CS; Mckillop, J; Whatelely, AT; Wilmott, N | 1 |
2 other study(ies) available for angiotensin ii and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
[Induced hypertensive chemotherapy with angiotensin II found effective for mediastinal lymph node metastases of unknown origin].
Topics: Adenocarcinoma; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Middle Aged; Mitomycin; Neoplasms, Unknown Primary | 2000 |
The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs.
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Colonic Neoplasms; Doxorubicin; Drug Carriers; Humans; Infusions, Intra-Arterial; Iodine Radioisotopes; Liver Neoplasms; Microspheres; Middle Aged; Mitomycin; Neoplasms, Unknown Primary; Radionuclide Imaging; Rectal Neoplasms; Regional Blood Flow; Technetium | 1992 |